Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12824054rdf:typepubmed:Citationlld:pubmed
pubmed-article:12824054lifeskim:mentionsumls-concept:C0600251lld:lifeskim
pubmed-article:12824054lifeskim:mentionsumls-concept:C0007785lld:lifeskim
pubmed-article:12824054lifeskim:mentionsumls-concept:C1537647lld:lifeskim
pubmed-article:12824054lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:12824054lifeskim:mentionsumls-concept:C0678951lld:lifeskim
pubmed-article:12824054pubmed:issue1lld:pubmed
pubmed-article:12824054pubmed:dateCreated2003-6-25lld:pubmed
pubmed-article:12824054pubmed:abstractTextInterleukin-1 (IL-1) has pleiotropic actions in the central nervous system. During the last decade, a growing corpus of evidence has indicated an important role of this cytokine in the development of brain damage following cerebral ischemia. The expression of IL-1 in the brain is dramatically increased during the early and chronic stage of infarction. The IL-1 gene cluster on chromosome 2q14 contains three related genes (IL1alpha, IL1beta, and IL1 receptor antagonist) located within a 430-kb region. T and C alleles exist for the IL-1alpha-889 regulatory region and the TT genotype has been reported to increase the production of the protein in lipopolysaccharide (LPS)-stimulated mononuclear cells from IL-1alpha-889 TT carriers. We examined whether the IL-1alpha polymorphism affects the probability of cerebral infarction (CI). We genotyped 360 CI patients and 519 healthy controls for the same polymorphism. A significant increase was found for the IL-1alpha T allele in CI patients compared with controls (chi2=5.026, P=0.025). We conclude that the IL-1alpha-889 polymorphism is a major risk factor for CI in Koreans.lld:pubmed
pubmed-article:12824054pubmed:languageenglld:pubmed
pubmed-article:12824054pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12824054pubmed:citationSubsetIMlld:pubmed
pubmed-article:12824054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12824054pubmed:statusMEDLINElld:pubmed
pubmed-article:12824054pubmed:monthJullld:pubmed
pubmed-article:12824054pubmed:issn0169-328Xlld:pubmed
pubmed-article:12824054pubmed:authorpubmed-author:KimHyung-MinH...lld:pubmed
pubmed-article:12824054pubmed:authorpubmed-author:LeeKang-MinKMlld:pubmed
pubmed-article:12824054pubmed:authorpubmed-author:MoonByung-Soo...lld:pubmed
pubmed-article:12824054pubmed:authorpubmed-author:UmJae-YoungJYlld:pubmed
pubmed-article:12824054pubmed:authorpubmed-author:ChoKwang-HoKHlld:pubmed
pubmed-article:12824054pubmed:authorpubmed-author:MoonKyung-Suk...lld:pubmed
pubmed-article:12824054pubmed:authorpubmed-author:YunJong-MinJMlld:pubmed
pubmed-article:12824054pubmed:issnTypePrintlld:pubmed
pubmed-article:12824054pubmed:day4lld:pubmed
pubmed-article:12824054pubmed:volume115lld:pubmed
pubmed-article:12824054pubmed:ownerNLMlld:pubmed
pubmed-article:12824054pubmed:authorsCompleteYlld:pubmed
pubmed-article:12824054pubmed:pagination50-4lld:pubmed
pubmed-article:12824054pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:meshHeadingpubmed-meshheading:12824054...lld:pubmed
pubmed-article:12824054pubmed:year2003lld:pubmed
pubmed-article:12824054pubmed:articleTitleAssociation of interleukin-1 alpha gene polymorphism with cerebral infarction.lld:pubmed
pubmed-article:12824054pubmed:affiliationDepartment of Pharmacology, College of Oriental Medicine, Kyung Hee University, 1 Hoegi-dong, Dongdaemun-gu, Seoul 130-701, South Korea.lld:pubmed
pubmed-article:12824054pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12824054pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3552entrezgene:pubmedpubmed-article:12824054lld:entrezgene
entrez-gene:3553entrezgene:pubmedpubmed-article:12824054lld:entrezgene
entrez-gene:3557entrezgene:pubmedpubmed-article:12824054lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12824054lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12824054lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12824054lld:entrezgene